Brand Intelligence Graph
Company Overview
About Earendil Labs
Earendil Labs is a full-stack AI biologics company that uses a proprietary AI platform to design protein therapeutics at scale. The company secured $787 million in financing in March 2026, backed by Sanofi, the Pfizer-Hillhouse Biotech Fund, Dimension Capital, and DST Global — one of the largest AI drug discovery raises in the industry's history.
Business Model & Competitive Advantage
The scale of Sanofi's involvement underscores Earendil's platform credibility: the companies signed a $2.56 billion collaboration agreement in January 2026, under which Sanofi gains access to Earendil's AI-generated biologics pipeline across multiple therapeutic areas. The partnership was followed by the broader financing round just weeks later, with Pfizer and DST providing additional validation from both strategic and growth-investment perspectives.
Competitive Landscape 2025–2026
Earendil's AI platform has generated over 40 drug programs, with a Phase 2-ready asset for inflammatory bowel disease among its most advanced candidates. The company is positioning itself as a new model for pharmaceutical R&D — one where AI can generate, screen, and optimize biologics programs in silico before any wet lab work, compressing timelines and reducing the capital intensity of early-stage drug discovery.
Key Differentiators
Strong Challenger
Earendil Labs is an established challenger with significant market presence and competitive offerings in BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Relay Therapeutics
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Iambic Therapeutics
Iambic Therapeutics was founded in 2019 with the mission of applying AI-driven drug discovery to oncology — one of the most complex and high-value areas of pharmaceutical development. The company buil
Xaira Therapeutics
Xaira Therapeutics is an AI-powered drug discovery company launched from stealth in April 2024 with $1 billion in committed capital. Headquartered in South San Francisco, incubated by Arch Venture Par
Converge Bio
Converge Bio is an Israeli AI drug discovery company using machine learning to design and optimize small molecule therapeutics across a broad portfolio of programs. Founded by a team with deep experti
Isomorphic Labs
Isomorphic Labs is an Alphabet company spun out of Google DeepMind to apply AI to the full drug discovery pipeline, from target identification through molecular design and clinical candidate selection
Compare Earendil Labs with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Earendil Labs? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Earendil Labs Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Earendil Labs vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →